Eli Lilly Sues Over US Sales of Bogus Mounjaro for Weight Loss Eli Lilly Sues Over US Sales of Bogus Mounjaro for Weight Loss

Eli Lilly on Tuesday said it was suing 10 US medical spas, wellness centers, and compounding pharmacies for selling products claiming to contain tirzepatide, the active ingredient in its diabetes drug Mounjaro.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news